Choroidal Neovascularization Associated with Extensive Macular Atrophy and Pseudodrusen
- 1 April 2015
- journal article
- case report
- Published by Wiley in Optometry and Vision Science
- Vol. 92 (4S) , S51-4
Abstract
Purpose: To describe a case of extensive macular atrophy and pseudodrusen complicated by bilateral choroidal neovascularization (CNV). Methods: A 53‐year‐old woman showed extensive macular atrophy at the posterior pole associated with disciform scar in the right eye and fibrotic juxtafoveal CNV in the left eye. Results: The patient underwent a complete ophthalmological examination including fundus autofluorescence, fluorescein angiography, and spectral‐domain optical coherence tomography, showing a disciform scar at the posterior pole of the right eye and an extensive macular atrophy associated with a fibrotic juxtafoveal CNV. The patient was previously treated with four and seven intravitreal bevacizumab injections, respectively, in the right eye and in the left eye. Molecular analyses of the ABCA4 gene revealed the variant c.1268A<G. Conclusions: Although the natural course of extensive macular atrophy and pseudodrusen usually leads to the enlargement of the macular atrophy, extensive macular atrophy and pseudodrusen can also complicate with bilateral CNV. Intravitreal bevacizumab can help stop the CNV activity.Keywords
This publication has 8 references indexed in Scilit:
- Extensive Macular Atrophy with Pseudodrusen-like AppearanceOphthalmology, 2013
- Analysis of Progression of Reticular Pseudodrusen by Spectral Domain–Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2012
- PATHOLOGIC INSIGHTS FROM INTEGRATED IMAGING OF RETICULAR PSEUDODRUSEN IN AGE-RELATED MACULAR DEGENERATIONRetina, 2011
- Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization Associated with Pattern DystrophyInvestigative Ophthalmology & Visual Science, 2010
- Reticular Pseudodrusen Are Subretinal Drusenoid DepositsOphthalmology, 2010
- Extensive Macular Atrophy With Pseudodrusen-like Appearance: A New Clinical EntityAmerican Journal of Ophthalmology, 2009
- Extensive Macular Atrophy with Pseudodrusen-like Appearance: A New Clinical EntityAmerican Journal of Ophthalmology, 2009
- Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt’s diseaseGraefe's Archive for Clinical and Experimental Ophthalmology, 2007